Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methylphenidate treatment.

Peter Weber1, Jürg Lütschg

  • 1University Children's Hospital, Department of Neuropediatrics, P.O. Box, CH-4005, Basel, Switzerland.

Pediatric Neurology
|May 7, 2002
PubMed
Summary

Methylphenidate is a common ADHD treatment, but its use in children with neurological conditions like epilepsy or brain injuries remains controversial due to limited efficacy and side effect data.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Value of Bronchoalveolar Lavage in Systemic Autoimmune Rheumatic Diseases-Associated Interstitial Lung Disease.

Journal of clinical medicine·2026
Same author

TBL1X/TBL1XR1 govern β-cell identity through a PAX6-containing gene regulatory network.

Nature communications·2026
Same author

Beta cell-targeted PD-1 agonist inhibits cell-mediated autoimmunity in pancreas tissue slices.

Science advances·2026
Same author

CRUSADE project: Recycling technologies for ELV components to create a sustainable source of market grade materials for EU applications.

Computational and structural biotechnology journal·2026
Same author

Ultrasound-measured enlargement of the cross-sectional area of the median nerve as a marker for early neuronal lesions in pediatric type 1 diabetes.

Scientific reports·2025
Same author

Inhibition of cell-mediated immunity in type 1 diabetes by beta cell-targeted PD-1 agonists in pancreas tissue slices.

bioRxiv : the preprint server for biology·2025

Area of Science:

  • Pediatric Neurology
  • Child Psychiatry
  • Neurodevelopmental Disorders

Background:

  • Methylphenidate is a widely prescribed psychostimulant for Attention-Deficit/Hyperactivity Disorder (ADHD).
  • Attention deficits are also observed in various childhood neurological diseases.
  • The use of methylphenidate in these specific pediatric neurological populations is not well-established and remains a subject of debate.

Purpose of the Study:

  • To review the current literature on the efficacy and side effects of methylphenidate in children with specific neurological conditions.
  • To highlight the existing gaps in knowledge regarding methylphenidate use in pediatric neurological disorders.
  • To encourage further controlled research in this clinical area.

Main Methods:

  • Literature review of existing studies on methylphenidate in children with neurological conditions.
  • Analysis of available data on efficacy and adverse events.
  • Identification of research gaps and controversies.

Main Results:

  • Limited data exists on the effectiveness and safety of methylphenidate in children with epilepsy, brain tumors, leukemia, closed brain injury, encephalitis, meningitis, or mental retardation.
  • The use of methylphenidate in these populations is controversial.
  • Further controlled investigations are needed.

Conclusions:

  • The efficacy and side effect profile of methylphenidate in children with various neurological conditions require further investigation.
  • Controlled studies are essential to establish appropriate treatment guidelines for methylphenidate in pediatric neurological disorders.
  • This review aims to stimulate such necessary future research.

Related Experiment Videos